Revelation Biosciences, Inc. (REVB) Stock in Slump, Here’s Why
Revelation Biosciences, Inc. (REVB), a clinical-stage biopharmaceutical company, closed Tuesday’s regular trading session at $0.95 after declining by more than 4.62% during the day. In the premarket, REVB stock has further slumped by 2.11% and as a result, is trading at $0.93 at the time of the writing. REVB Hosted Conference Call The most recent […]